Delivery Order SPE2DB22D3501-SPE2DB24FTX94
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The contract has a ceiling value of $1,708.81 and a period of performance through March 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,336.60 firm fixed-price delivery order is for the procurement of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a medical product, with a completion date of December 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,203,919 units of the pharmaceutical product Dexmedetomidine 200 mcg/2 ml 2 ml. The order has a ceiling value of $4,104.39 and a period of performance through April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $1,577.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexmedetomidine 200 MCG/2 ML in 2 ML vials. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a relatively small-value transaction within the company's broader pharmaceutical supply portfolio...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,117.21, is for the delivery of DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a specialty medication. This appears to be a firm-fixed-price delivery order contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, awarded a $235,040 delivery order contract to Amerisourcebergen Drug Corporation for 4561376348 DEXMEDETOMIDINE 200MCG/50ML-NS 50ML. The contract has a period of performance from June 29, 2023 through June 30, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The award was made using a firm fixed price contracting method against an existing DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,648.87 firm fixed-price delivery order is for the supply of DEXMEDETOMIDINE 200MCG/50ML-NS 50ML, a medical product used for various healthcare applications. The contract has an ultimate completion date of January 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,543.69 firm fixed-price contract is for the supply of Dexmedetomidine 400mcg/100ml-NS 100ml, a medication used for sedation. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563316530 - DEXMEDETOMIDINE 200 MCG/2 ML 2ML, a specialty medication. The contract has a firm fixed price of $1,453.12 and a completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This delivery order, valued at $1,278.66, awards AmerisourceBergen Drug Corp a contract to supply Dexmedetomidine 400mcg/100mL in 100mL vials to the Defense Logistics Agency's Medical Supply Chain. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 29, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTX94Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563155019 DEXMEDETOMIDINE 200 MCG/2 ML 2ML pharmaceuticals. The $1,003.69 delivery order has a completion date of December 21, 2023 and was awarded on December 20, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has an extensive history of providing pharmaceuticals, medical supplies, and distribution services to the Department of Defense under various DLA Troop Support Medical contracts. The parent company, Cencora, Inc., also operates under the Amerisourcebergen name. This award is issued against an indefinite delivery contract held by Amerisourcebergen Drug Corp with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/20/23 |